These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26473153)

  • 1. Efficacy of two-time prophylactic intravenous administration of tazobactam/piperacillin for transrectal ultrasound-guided needle biopsy of the prostate.
    Iwamoto H; Shigehara K; Miyagi T; Nakashima T; Shimamura M; Namiki M
    Prostate Int; 2015 Sep; 3(3):103-6. PubMed ID: 26473153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.
    Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A
    J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.
    Kobayashi I; Ikawa K; Nakamura K; Nishikawa G; Kajikawa K; Yoshizawa T; Watanabe M; Kato Y; Zennami K; Kanao K; Tobiume M; Yamada Y; Mitsui K; Narushima M; Morikawa N; Sumitomo M
    J Infect Chemother; 2015 Aug; 21(8):575-80. PubMed ID: 26050020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
    Iwai N; Nakamura H; Miyazu M
    Jpn J Antibiot; 1998 May; 51(5):346-61. PubMed ID: 9693967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1998 May; 51(5):325-45. PubMed ID: 9693966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laboratory and clinical studies on tazobactam/piperacillin in the field of pediatrics].
    Kuno K; Ogawa A; Hayakawa F; Miyajima Y; Takahashi H; Okumura A; Kato T; Itomi K
    Jpn J Antibiot; 1998 Jun; 51(6):395-406. PubMed ID: 9755829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing ceftolozane/tazobactam versus piperacillin/tazobactam for the initial empiric therapy of urinary tract infections: A retrospective comparative study.
    Nakagawa T; Shigehara K; Shinzawa R; Yaegashi H; Kawaguchi S; Nohara T; Izumi K; Mizokami A
    J Infect Chemother; 2024 Jan; 30(1):12-16. PubMed ID: 37660735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
    Oizumi K; Ohno T; Kawahara M; Kawaguchi S; Saisho M; Mitutake Y; Saito A; Tomizawa M; Koike T; Takebe K
    Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial prophylaxis for transurethral resection of bladder tumor: A retrospective comparison of preoperative single-dose administration of piperacillin and tazobactam/piperacillin.
    Murakami M; Kiyota H; Kasai K; Bando S; Kira S; Koide H; Yamada H; Kimura T; Egawa S
    J Infect Chemother; 2018 Dec; 24(12):954-957. PubMed ID: 30193786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antibiotic susceptibility of Escherichia coli between community-acquired and post-prostate biopsy acute bacterial prostatitis.
    Park MG; Cho MC; Cho SY; Lee JW
    Arch Esp Urol; 2019 Dec; 72(10):1018-1025. PubMed ID: 31823850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].
    Fukasawa C; Hoshino T; Kutsuna S; Sawada K; Sato H; Ishiwada N
    Kansenshogaku Zasshi; 2013 Sep; 87(5):590-5. PubMed ID: 24195168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field].
    Fujii R; Okuno A; Fujita K; Yoshikawa M; Inyaku F; Takimoto M; Saijo M; Wagatsuma S; Fukushima N; Ishikawa A
    Jpn J Antibiot; 1995 Mar; 48(3):311-45. PubMed ID: 7752448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].
    Oizumi K; Kawahara M; Kawaguchi S; Sigematsu H; Tanaka F; Sano N; Saito A; Hiraga Y; Ohmichi M; Inoue H
    Jpn J Antibiot; 1995 Apr; 48(4):482-513. PubMed ID: 7783314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients].
    Sudo F; Ishiwada N; Hoshino T; Fukasawa C; Inami Y; Hishiki H; Takeda N; Kurosaki T; Kohno Y
    Kansenshogaku Zasshi; 2005 Sep; 79(9):637-43. PubMed ID: 16248372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro interaction of tazobactam/piperacillin combined with aminoglycosides against Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli AND Staphylococcus aureus].
    Yamada H; Takahata M; Minami S
    Jpn J Antibiot; 2002 Feb; 55(1):61-6. PubMed ID: 11977921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Ohuchida A; Taniguti A; Kouchi Y; Maeda Y; Kashihara A; Omae S
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():263-80. PubMed ID: 7830291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (2)--Teratological study in rats with intravenously administration].
    Sato T; Lochry EA; Hoberman AM; Christian MS
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():215-32. PubMed ID: 7830288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.